Posts Tagged ‘macular degeneration’
Could weight loss injections be affecting your eyes?
New Research Links GLP-1 Medications to Macular Degeneration Risk If you are taking popular weight loss or diabetes medications such as Ozempic, Wegovy or Mounjaro, it may be time to look more closely—at your eye health. A new large-scale study from the University of Toronto, published in JAMA Ophthalmology and featured in Optometry Today (June 2025),…
Read MoreNon-Invasive Dry AMD Therapy available in Kingston upon Thames, London
A breakthrough in photobiomodulation therapy for eye health — at John Rose Eye Care If you or a loved one has been diagnosed with dry Age-related Macular Degeneration (AMD) — or you are at risk and looking for proactive, private eye care in Richmond, Barnes, Surbiton, London or across Surrey — we invite you…
Read MoreProtect Your Vision For The Future – John Rose Optometrist Offers the Most Advanced Eye Care in Kingston upon Thames
When it comes to vision, settling for anything less than the best is simply not an option. John Rose, expert optometrist with over 40 years of experience, offers world-class eye care at his independent practice in Kingston upon Thames. Patients, from across the globe , seek his expertise, cutting-edge technology and personalised care. One of…
Read MoreDiscover the Latest in Dry AMD Treatment with John Rose Optometrist
Join optometrist John Rose in conversation with journalist Angela Young as they discuss the FDA-approved Valeda Light Delivery System (LDS) treatment for Dry Age-Related Macular Degeneration (AMD). Hear directly from John and Alita, one of our AMD patients, about how this innovative therapy works and their personal experience with Valeda. 🎧✨ Listen to the…
Read MoreThe Valeda LDS treatment for dry AMD is now FDA approved
LumiThera has received U.S. FDA authorisation to market its Valeda® Light Delivery System, the first FDA-approved treatment for vision loss due to dry age-related macular degeneration (AMD). The non-invasive photobiomodulation (PBM) device demonstrated improved visual acuity and safety over 24 months in the pivotal LIGHTSITE III trial, with results showing that Valeda slowed disease progression…
Read MoreEnhancing AMD Care with AI – Q & A with John Rose Optometrist, Kingston
AMD eye diagnostics and AI At John Rose Eye Care in Kingston upon Thames we are committed to leading the way in age-related macular degeneration (AMD) care, by being the first Optometric Practice in the UK to adopt the RetinSight AI software. This innovative technology is not just about leveraging AI; it’s about significantly enhancing…
Read MoreValeda LDS, the treatment for patients suffering from Dry Age-Related Macular Degeneration
Managing Dry Macular Degeneration (AMD) Age-Related Macular Degeneration is a gradual loss of vision that progresses with age. It normally affects central vision, particularly contrast sensitivity, dark adaptation, colour vision and depth perception – changes that influence performance and experience of day-to-day tasks and hobbies such as reading, driving, watching TV, painting etc. Early stages…
Read More